Description_Effects

Regperidon-200 contains Pirfenidone 200 mg, an antifibrotic and anti-inflammatory medication primarily used in the treatment of Idiopathic Pulmonary Fibrosis (IPF) — a chronic, progressive lung disease characterized by scarring (fibrosis) of lung tissue. The exact cause of IPF is unknown, but it leads to worsening breathlessness and reduced lung function over time. Pirfenidone, the active ingredient in Regperidon-200, works by reducing the production of certain chemical messengers (such as TGF-β and TNF-α) that are involved in inflammation and fibrosis. By slowing down the formation of scar tissue in the lungs and reducing inflammation, Pirfenidone helps preserve lung function and improves breathing capacity, thereby enhancing the quality of life for patients. Regperidon-200 is typically prescribed as part of a long-term management plan for IPF. It is not a cure, but studies have shown that Pirfenidone can slow disease progression, reduce lung function decline, and extend survival in some patients. Treatment should be initiated and monitored by a healthcare professional experienced in managing lung diseases. The medication is taken orally and usually started at a lower dose, which is gradually increased to the recommended maintenance dose. This gradual uptitration helps minimize common side effects, such as nausea, rash, fatigue, and gastrointestinal discomfort. It is advised to take the medicine with food to reduce the risk of stomach upset. Patients should also avoid excessive sun exposure, as Pirfenidone may increase skin sensitivity to sunlight. Regular monitoring of liver function is recommended during treatment, as liver enzyme elevations may occur. Patients should promptly report any signs of jaundice, persistent nausea, or unusual fatigue to their doctor. Regperidon-200 plays a key role in slowing the progression of IPF and allowing patients to maintain their daily activities for a longer period. It may also be used in research settings for other fibrotic lung conditions, though such uses are still being evaluated. This medication should only be used under strict medical supervision, and patients must adhere closely to the prescribed dosage and schedule. Discontinuation or dose adjustments should be done only on the advice of the treating physician.